IM Therapeutics Spins Out of University of Colorado to Focus on Type 1 Diabetes Post author:Sam Post published:November 9, 2017 Post category:BioPharma ImmunoMolecular Therapeputics officially launched yesterday. Source: BioSpace You Might Also Like Why Investors Should Dodge Gilead in 2018 December 28, 2017 Bay Area's Arcus Biosciences Scores $107M, Initiates Two Clinical Trials November 12, 2017 New Wirelessly Powered Scalable Retinal Prosthesis, University of California, San Diego (UCSD) Reveals March 16, 2017
New Wirelessly Powered Scalable Retinal Prosthesis, University of California, San Diego (UCSD) Reveals March 16, 2017